Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04834375 · ClinicalTrials.gov registry record · Phase 3
Randomized Open Investigation Determining Steroid Dose
A Phase 3 study, sponsored by Northwell Health.
- Completed
- Registry status
- Phase 3
- Development phase
- 142
- Enrollment target
NCT04834375 is a Phase 3 study that has completed, run by Northwell Health. The registered enrollment target is 142 participants.
The verdict
NCT04834375, a Phase 3 study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 142 participants
- Enrollment target
Study Summary
Dexamethasone has been approved for the treatment of severe COVID-19, but higher doses of steroids may be more effective. The purpose of this research study is to compare the current standard dose of dexamethasone 6 mg to a higher, weight-based dosing (0.2 mg/kg with maximum dose of 20 mg) to determine if it would be more effective against COVID-19 pneumonia.
Interventions
- DRUG Weight-based dexamethasone dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2021-03-19 |
| Est. Completion | 2022-03-29 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04834375
The ClinicalTrials.gov registry entry for NCT04834375 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Weight-based dexamethasone dose is the first listed.
NCT04834375 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04834375 about?
NCT04834375 is a clinical study titled "Randomized Open Investigation Determining Steroid Dose". Dexamethasone has been approved for the treatment of severe COVID-19, but higher doses of steroids may be more effective. The purpose of this research study is to compare the current standard dose of dexamethasone 6 mg to a higher, weight-based dosing (0.2 mg/kg with maximum dose of 20 mg) to determ...
What is the current status of trial NCT04834375?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 142 participants. The study started on 2021-03-19. Estimated completion is 2022-03-29.
What interventions are being tested in trial NCT04834375?
The interventions under investigation include: Weight-based dexamethasone dose (DRUG).
Who is sponsoring clinical trial NCT04834375?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.